Minute ventilation in infants with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 529s Year: 2002
Infection and inflammation does not effect ventilation distribution in infants with cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease Year: 2011
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Time constant of respiratory muscle relaxation in patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Agreement between the lung clearance index and bronchiectasis detected via chest computed tomography in infants and children with cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection Source: Eur Respir J 2015; 46: 1680-1690 Year: 2015
Clinical value of lung clearance index (LCI) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Lung MRI findings in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Noninvasive ventilation (NPPV) affects Pulmonary Exacerbation (PE) rate in Cystic Fibrosis children (CFc). Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018
Quantitative evaluation of CF airways using HRCT, µCT and histology Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014
Difficulties in optimizing vitamin D levels in paediatric cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014
Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Normal lung function in infants with cystic fibrosis shortly after birth Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013
Annual change of LCI among patients with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016
Long-term repeatability of ventilation inhomogeneity in healthy infants and those with cystic fibrosis (CF) Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004